126.41

1.76% -2.49

Agilent Technologies Inc (A)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché A Giù? Forum Previsione Frazionamento azionario Storia dei dividendi

Precedente Chiudi:

$128.90

Aprire:

$129

Volume 24 ore:

320.18K

Relative Volume:

0.16

Capitalizzazione di mercato:

$35.78B

Reddito:

$6.95B

Utile/perdita netta:

$1.30B

Rapporto P/E:

27.66

EPS:

4.5696

Flusso di cassa netto:

$1.15B

1 W Prestazione:

-2.32%

1M Prestazione:

-14.43%

6M Prestazione:

+7.94%

1 anno Prestazione:

-8.29%

Intervallo 1D:

$125.26

$129.00

Intervallo di 1 settimana:

$125.26

$131.43

Portata 52W:

$96.43

$160.27

Agilent Technologies Inc Stock (A) Company Profile

Nome

Agilent Technologies Inc

Settore

Healthcare (1116)

Industria

Diagnostics & Research (52)

Telefono

(408) 345-8886

Indirizzo

5301 STEVENS CREEK BLVD, SANTA CLARA, CA

Dipendente

18,100

Cinguettio

@agilent

Prossima data di guadagno

2025-11-24

Ultimi documenti SEC

A's Discussions on Twitter

Compare A vs TMO, DHR, IDXX, WAT

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
A Agilent Technologies Inc	126.50	36.46B	6.95B	1.30B	1.15B	4.5696
TMO Thermo Fisher Scientific Inc	506.11	198.06B	44.56B	6.73B	6.29B	17.74
DHR Danaher Corp	214.59	155.50B	24.57B	3.60B	5.25B	5.0475
IDXX Idexx Laboratories Inc	637.28	51.80B	4.30B	1.06B	1.04B	13.08
WAT Waters Corp	317.58	32.29B	3.11B	648.81M	602.27M	10.88

Agilent Technologies Inc Stock (A) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-01-20	Iniziato	HSBC Securities	Buy
2026-01-05	Aggiornamento	Evercore ISI	In-line → Outperform
2025-12-15	Aggiornamento	Barclays	Equal Weight → Overweight
2025-12-09	Iniziato	Goldman	Buy
2025-12-02	Iniziato	Morgan Stanley	Overweight
2025-10-08	Iniziato	Rothschild & Co Redburn	Buy
2025-10-08	Aggiornamento	UBS	Neutral → Buy
2025-02-10	Aggiornamento	Barclays	Underweight → Equal Weight
2024-08-28	Iniziato	Wells Fargo	Overweight
2024-07-10	Aggiornamento	Citigroup	Neutral → Buy
2024-06-27	Downgrade	Wolfe Research	Outperform → Peer Perform
2024-06-03	Ripresa	Jefferies	Hold
2024-04-05	Aggiornamento	Stifel	Hold → Buy
2023-12-13	Iniziato	Wolfe Research	Outperform
2023-12-12	Downgrade	BofA Securities	Buy → Neutral
2023-11-17	Downgrade	UBS	Buy → Neutral
2023-09-28	Iniziato	Bernstein	Mkt Perform
2023-07-31	Downgrade	Evercore ISI	Outperform → In-line
2023-05-24	Reiterato	Barclays	Equal Weight
2023-05-24	Reiterato	BofA Securities	Buy
2023-05-24	Reiterato	Citigroup	Neutral
2023-05-24	Reiterato	Credit Suisse	Outperform
2023-05-24	Reiterato	Evercore ISI	Outperform
2023-05-24	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
2023-05-24	Reiterato	Robert W. Baird	Outperform
2023-05-24	Reiterato	SVB Securities	Outperform
2023-05-24	Reiterato	Stifel	Hold
2023-05-24	Reiterato	TD Cowen	Outperform
2023-05-24	Reiterato	Wells Fargo	Overweight
2023-05-11	Iniziato	Barclays	Equal Weight
2023-01-10	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2022-08-25	Iniziato	Credit Suisse	Outperform
2022-07-20	Iniziato	UBS	Buy
2022-07-08	Downgrade	Citigroup	Buy → Neutral
2022-04-25	Downgrade	Wells Fargo	Overweight → Equal Weight
2022-02-23	Reiterato	BofA Securities	Buy
2022-02-23	Reiterato	Citigroup	Buy
2022-02-23	Reiterato	Cowen	Outperform
2022-02-23	Reiterato	Evercore ISI	Outperform
2022-02-23	Reiterato	Stifel	Hold
2022-02-23	Reiterato	Wells Fargo	Overweight
2021-11-23	Reiterato	BofA Securities	Buy
2021-11-23	Reiterato	Cowen	Outperform
2021-11-23	Reiterato	Stifel	Hold
2021-03-18	Aggiornamento	Citigroup	Neutral → Buy
2021-02-17	Aggiornamento	BofA Securities	Neutral → Buy
2020-12-02	Iniziato	Goldman	Buy
2020-11-25	Aggiornamento	UBS	Neutral → Buy
2020-11-17	Aggiornamento	Cleveland Research	Neutral → Buy
2020-11-10	Iniziato	KeyBanc Capital Markets	Overweight
2020-09-30	Iniziato	Atlantic Equities	Neutral
2020-08-19	Reiterato	BofA Securities	Neutral
2020-08-19	Reiterato	Citigroup	Neutral
2020-08-19	Reiterato	Jefferies	Buy
2020-08-19	Reiterato	Robert W. Baird	Outperform
2020-08-19	Reiterato	SVB Leerink	Outperform
2020-08-19	Reiterato	Stifel	Hold
2020-08-19	Reiterato	Wells Fargo	Overweight
2020-02-24	Downgrade	Needham	Buy → Hold
2020-01-08	Iniziato	Wells Fargo	Overweight
2020-01-07	Iniziato	Citigroup	Neutral
2019-11-26	Reiterato	Needham	Buy
2019-11-15	Iniziato	Stifel	Hold
2019-10-18	Downgrade	UBS	Buy → Neutral
2019-07-16	Downgrade	BofA/Merrill	Buy → Neutral
2019-07-15	Downgrade	Barclays	Overweight → Equal Weight

Mostra tutto

Agilent Technologies Inc Borsa (A) Ultime notizie

Feb 11, 2026

Agilent (A) Secures FDA Approval for Key Cancer Diagnostic Tool - GuruFocus

Feb 11, 2026

Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (EOC) - Yahoo Finance

Feb 11, 2026

Agilent Announces Cash Dividend of 25.5 Cents per Share - 01net

Feb 11, 2026

Agilent presents Boehringer Ingelheim with inaugural 2025 instrument Trade-in Impact Award - marketscreener.com

Feb 11, 2026

Agilent Slumps After Awarding Boehringer - Baystreet.ca

Feb 11, 2026

Agilent's Ovarian Cancer Diagnostic Test Receives FDA Clearance - marketscreener.com

Feb 11, 2026

FDA Approval Boosts Agilent Technologies (A) Diagnostic Tool - GuruFocus

Feb 11, 2026

Agilent Presents Boehringer Ingelheim With Inaugural 2025 Instrument Trade‑In Impact Award - Bluefield Daily Telegraph

Feb 11, 2026

Madison Asset Management LLC Sells 14,089 Shares of Agilent Technologies, Inc. $A - MarketBeat

Feb 11, 2026

Gas Chromatography Detector Market Is Going to Boom |• Agilent Technologies • Thermo Fisher Scientific - openPR.com

Feb 11, 2026